Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis
収録刊行物
-
- J. Pharmacol. Exp. Ther.
-
J. Pharmacol. Exp. Ther. 219 299-308, 1981